This HTML5 document contains 51 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dctermshttp://purl.org/dc/terms/
n14http://linked.opendata.cz/resource/domain/vavai/riv/tvurce/
n15http://linked.opendata.cz/ontology/domain/vavai/
n6http://linked.opendata.cz/resource/domain/vavai/vysledek/RIV%2F00064203%3A_____%2F07%3A2886%21RIV12-MZ0-00064203/
shttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
n5http://linked.opendata.cz/ontology/domain/vavai/riv/
skoshttp://www.w3.org/2004/02/skos/core#
n2http://linked.opendata.cz/resource/domain/vavai/vysledek/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n13http://linked.opendata.cz/ontology/domain/vavai/riv/klicoveSlovo/
n11http://linked.opendata.cz/ontology/domain/vavai/riv/duvernostUdaju/
xsdhhttp://www.w3.org/2001/XMLSchema#
n16http://linked.opendata.cz/ontology/domain/vavai/riv/jazykVysledku/
n12http://linked.opendata.cz/ontology/domain/vavai/riv/aktivita/
n17http://linked.opendata.cz/ontology/domain/vavai/riv/obor/
n7http://linked.opendata.cz/ontology/domain/vavai/riv/druhVysledku/
n8http://reference.data.gov.uk/id/gregorian-year/

Statements

Subject Item
n2:RIV%2F00064203%3A_____%2F07%3A2886%21RIV12-MZ0-00064203
rdf:type
n15:Vysledek skos:Concept
rdfs:seeAlso
http://www.nature.com/leu/journal/v21/n2/abs/2404484a.html
dcterms:description
Juvenile myelomonocytic leukemia (JMML) is a clonal myeloproliferative/myelodysplastic disorder of young children. Allogeneic hematopoietic stem cell transplantation (HSCT) is the only curative therapy, and a recent report from the European working group on myelodysplastic syndrome in Childhood (EWOG-MDS) indicates an event-free survival (EFS) of 52% at 5 years after HSCT Juvenile myelomonocytic leukemia (JMML) is a clonal myeloproliferative/myelodysplastic disorder of young children. Allogeneic hematopoietic stem cell transplantation (HSCT) is the only curative therapy, and a recent report from the European working group on myelodysplastic syndrome in Childhood (EWOG-MDS) indicates an event-free survival (EFS) of 52% at 5 years after HSCT
dcterms:title
JAK2 V617F mutation is a rare event in juvenile myelomonocytic leukemia JAK2 V617F mutation is a rare event in juvenile myelomonocytic leukemia
skos:prefLabel
JAK2 V617F mutation is a rare event in juvenile myelomonocytic leukemia JAK2 V617F mutation is a rare event in juvenile myelomonocytic leukemia
skos:notation
RIV/00064203:_____/07:2886!RIV12-MZ0-00064203
n5:aktivita
n12:V
n5:aktivity
V
n5:cisloPeriodika
2
n5:dodaniDat
n8:2012
n5:domaciTvurceVysledku
n14:4977939
n5:druhVysledku
n7:J
n5:duvernostUdaju
n11:S
n5:entitaPredkladatele
n6:predkladatel
n5:idSjednocenehoVysledku
427918
n5:idVysledku
RIV/00064203:_____/07:2886
n5:jazykVysledku
n16:eng
n5:klicovaSlova
leukemia; oncology
n5:klicoveSlovo
n13:oncology n13:leukemia
n5:kodStatuVydavatele
GB - Spojené království Velké Británie a Severního Irska
n5:kontrolniKodProRIV
[57CD38270A64]
n5:nazevZdroje
Leukemia
n5:obor
n17:FD
n5:pocetDomacichTvurcuVysledku
1
n5:pocetTvurcuVysledku
16
n5:rokUplatneniVysledku
n8:2007
n5:svazekPeriodika
21
n5:tvurceVysledku
Sainati, L. Danesino, C. Bergsträsser, E. Bergamaschi, G. Locatelli, F. De Filippi, P. Hasle, H. Niemeyer, CM Wojcik, D. Trebo, M. Starý, Jan Zecca, M. Pension, A. Lisini, D. Kratz, C. Van den, Heuvel-Eibrink
n5:wos
000243729800031
s:issn
0887-6924
s:numberOfPages
3